Abstract: RISC-V is an open-standard Instruction Set Architecture (ISA) that has gained significant popularity in both academia and industry. The adoption of RISC-V is propelled by open-source ...

Recursion Pharmaceuticals Inc. has prepared and tested new 1-phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) inhibitors reported to be useful for the treatment of interstitial lung disease, liver, ...

EVM still powers the ecosystem due to tooling, trust, and compatibility. Vitalik’s April 2025 proposal aims to replace the EVM with RISC-V, an open instruction set architecture. RISC-V offers ...

Visualize recursion in real-time — watch the call stack grow & shrink with stack and tree views. Built with HTML, CSS, JS (Canvas).

We would like to express our sincere gratitude to Dr. John Wickerson for his exceptional IAC lectures that formed the foundation of this project. His clear explanations of compiler architecture and ...

Abstract: We have been developing MEIMAT (MEiji Microprocessor Architecture Design Tools). The MEIMAT is essentially designed to be able to represent any instruction of various processors by the ...

Chris Gibson, PhD, Recursion’s co-founder and CEO, discusses exclusively with GEN Edge his company’s ambitious plans to develop 100 pipeline candidates in roughly a decade, the savings in money and ...

Recursion Pharmaceuticals Inc. has synthesized molecular glue degraders acting as RBM39 degradation inducers reported to be useful for the treatment of renal cell carcinoma.

Many have waited years to hear someone like Prahlad Venkatapuram, Senior Director of Engineering at Meta, say what came out this week at the RISC-V Summit: “We’ve identified that RISC-V is the way to ...

One of the largest vendors of embedded processors has independently developed a CPU core for the 32-bit general-purpose RISC-V market; it can be used as the main CPU or on-chip subsystem and can even ...